(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Fascioliasis D005211 3 associated lipids
Fatigue D005221 10 associated lipids
Fatty Liver D005234 48 associated lipids
Fetal Macrosomia D005320 3 associated lipids
Forearm Injuries D005543 1 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gastroenteritis D005759 4 associated lipids
Glioma D005910 112 associated lipids
Glycogen Storage Disease Type I D005953 4 associated lipids
Glycogen Storage Disease D006008 4 associated lipids
Glycogen Storage Disease Type III D006010 2 associated lipids
Glycosuria D006029 10 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Heart Septal Defects D006343 2 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Hepatitis, Chronic D006521 3 associated lipids
Hepatitis, Viral, Human D006525 3 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperglycemia D006943 21 associated lipids
Hyperglycemic Hyperosmolar Nonketotic Coma D006944 4 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperlipidemia, Familial Combined D006950 9 associated lipids
Hypertension D006973 115 associated lipids
Hypocalcemia D006996 12 associated lipids
Hypoglycemia D007003 13 associated lipids
Hyponatremia D007010 5 associated lipids
Hypopituitarism D007018 7 associated lipids
Hypothyroidism D007037 32 associated lipids
Infant, Newborn, Diseases D007232 9 associated lipids
Insulin Coma D007331 2 associated lipids
Insulin Resistance D007333 99 associated lipids
Intestinal Diseases D007410 6 associated lipids
Jaundice D007565 4 associated lipids
Kearns-Sayre Syndrome D007625 2 associated lipids
Ketosis D007662 13 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Lacrimal Apparatus Diseases D007766 1 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Lipidoses D008064 7 associated lipids
Lipoma D008067 1 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Liver Diseases D008107 31 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mastitis D008413 3 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Lomas AJ et al. Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate)/collagen hybrid scaffolds for tissue engineering applications. 2013 Tissue Eng Part C Methods pmid:23281705
Sato T et al. Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. 1998 Tohoku J. Exp. Med. pmid:9710942
Ally AI et al. Trimethyltin as a selective adrenal chemosympatholytic agent in vivo: effect precedes both clinical and histopathological evidence of toxicity. 1986 Toxicology pmid:3726895
Cahill GF and Veech RL Ketoacids? Good medicine? 2003 Trans. Am. Clin. Climatol. Assoc. pmid:12813917
Sasi P et al. Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions. 2006 Trans. R. Soc. Trop. Med. Hyg. pmid:16257025
Whisson ME et al. Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. 1993 Transfus Med pmid:8374698
Laird MD et al. Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels. 2013 Transl Stroke Res pmid:24323418
Yamaguchi M et al. Evaluation of temporary portal vein arterialization: the minimum arterialized blood flow for maintaining liver viability. 1990 Transpl. Int. pmid:2271087
Igea J et al. Evaluation of beta-oxidation parameters and mitochondrial redox state as early markers of hepatic function in hepatic transplantation. 1999 Transplant. Proc. pmid:10500662
Kitabayashi K et al. Arterial ketone body ratio in clinical liver transplantation. 1998 Transplant. Proc. pmid:9865382